Fitterfly personalises diabetes management with digital therapeutics

A.SingalA.Singal
BulletArticle
RED 2021 Healthcare Transformation
共享以下内容：
复制链接
Fitterfly personalises diabetes management with digital therapeutics (RED 2021)

Fitterfly is an India-based company that provides solutions for chronic disease management. In this session, Fitterfly CEO and Co-Founder Dr Arbinder Singal discusses Diabefly, a digital therapeutics system that collects and analyses personal health data in order to deliver medical and lifestyle interventions.

Watch the full talk below.

共享以下内容：
复制链接

有关同一主题的更多信息

Gemii leverages WeChat to improve Chinese healthcare

Asia’s rapidly changing health insurance landscape (RED 2021)

推荐主题

SequencingRED 2020Rare Diseases
下次阅读
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
3 steps to mitigate the impact of interference
  • Clinician Engagement, Coagulation, Disease Area, Management
3 steps to mitigate the impact of interference
A guide to balancing quality, speed and cost
  • Operational Excellence, Operations
A guide to balancing quality, speed and cost
Scroll to Top